JP2572673B2 - 徐放性錠剤 - Google Patents

徐放性錠剤

Info

Publication number
JP2572673B2
JP2572673B2 JP2197019A JP19701990A JP2572673B2 JP 2572673 B2 JP2572673 B2 JP 2572673B2 JP 2197019 A JP2197019 A JP 2197019A JP 19701990 A JP19701990 A JP 19701990A JP 2572673 B2 JP2572673 B2 JP 2572673B2
Authority
JP
Japan
Prior art keywords
sustained
release
tablet
drugs
sustained release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2197019A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0482825A (ja
Inventor
実 岡田
哲男 林
収一 笠井
曜 岩佐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Priority to JP2197019A priority Critical patent/JP2572673B2/ja
Priority to KR1019910011776A priority patent/KR0169319B1/ko
Priority to CA002046845A priority patent/CA2046845C/en
Priority to US07/732,927 priority patent/US5164193A/en
Priority to TW080105645A priority patent/TW222592B/zh
Priority to DE69128569T priority patent/DE69128569T2/de
Priority to EP91112313A priority patent/EP0468436B1/en
Priority to ES91112313T priority patent/ES2111547T3/es
Publication of JPH0482825A publication Critical patent/JPH0482825A/ja
Application granted granted Critical
Publication of JP2572673B2 publication Critical patent/JP2572673B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2197019A 1990-07-25 1990-07-25 徐放性錠剤 Expired - Lifetime JP2572673B2 (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2197019A JP2572673B2 (ja) 1990-07-25 1990-07-25 徐放性錠剤
KR1019910011776A KR0169319B1 (ko) 1990-07-25 1991-07-11 서방성 정제
CA002046845A CA2046845C (en) 1990-07-25 1991-07-11 Sustained-release tablet
US07/732,927 US5164193A (en) 1990-07-25 1991-07-19 Sustained-release tablet
TW080105645A TW222592B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-07-25 1991-07-20
DE69128569T DE69128569T2 (de) 1990-07-25 1991-07-23 Tablette mit verzögerter Wirkstoffabgabe
EP91112313A EP0468436B1 (en) 1990-07-25 1991-07-23 Sustained-release tablet
ES91112313T ES2111547T3 (es) 1990-07-25 1991-07-23 Comprimido de liberacion prolongada.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2197019A JP2572673B2 (ja) 1990-07-25 1990-07-25 徐放性錠剤

Publications (2)

Publication Number Publication Date
JPH0482825A JPH0482825A (ja) 1992-03-16
JP2572673B2 true JP2572673B2 (ja) 1997-01-16

Family

ID=16367420

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2197019A Expired - Lifetime JP2572673B2 (ja) 1990-07-25 1990-07-25 徐放性錠剤

Country Status (8)

Country Link
US (1) US5164193A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0468436B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2572673B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR0169319B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2046845C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69128569T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2111547T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW222592B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0818990A1 (en) * 1995-04-03 1998-01-21 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
CA2216215A1 (en) * 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
FR2771291B1 (fr) * 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
WO2000074650A2 (en) * 1999-06-04 2000-12-14 Alza Corporation Implantable gel compositions and method of manufacture
EP1207852A4 (en) 1999-09-02 2009-11-11 Nostrum Pharmaceuticals Inc ORAL PHARMACEUTICALS WITH TAXED RELEASE FOR ORAL ADMINISTRATION
US20050037073A1 (en) * 2000-01-13 2005-02-17 Alpharx Inc. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
WO2002067905A1 (en) * 2001-02-27 2002-09-06 Kos Pharmaceuticals, Inc. A sustained release pharmaceutical formulation
KR100464592B1 (ko) * 2001-04-13 2004-12-31 주식회사 한국팜비오 포타슘시트레이트를 함유한 왁스 매트릭스 타입의 정제와그의 조성물
AU2002316582B2 (en) 2001-07-06 2007-03-15 Endo Pharmaceuticals, Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
RU2190408C1 (ru) * 2001-10-16 2002-10-10 Нестерук Владимир Викторович Лекарственное средство на основе пентоксифиллина
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
US20050031686A1 (en) * 2002-03-25 2005-02-10 Truffini & Regge' Farmaceutici Srl Gastroresistant tablets for alimentary, dietetic and therapeutic use
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
US20060105036A1 (en) 2003-05-12 2006-05-18 Stephen Peroutka Threo-dops controlled release formulation
US20050220877A1 (en) * 2004-03-31 2005-10-06 Patel Ashish A Bilayer tablet comprising an antihistamine and a decongestant
BRPI0518396A2 (pt) 2004-12-27 2008-11-18 Eisai R&D Man Co Ltd mÉtodo para estabilizaÇço de droga anti-demÊncia
US20090060993A1 (en) * 2007-09-04 2009-03-05 Joseph Schwarz Solid pharmaceutical composition for enhanced delivery of coenzyme q-10 and ubiquinones
JP5122380B2 (ja) * 2008-06-16 2013-01-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 薬物の放出を制御した速崩錠及びその製法
US8962020B2 (en) * 2012-07-26 2015-02-24 Glycadia Inc. Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid
EP3439676B1 (en) 2016-04-04 2021-06-09 Omeza LLC Fish oil topical composition
CA3088356A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
US10369134B2 (en) 2017-12-05 2019-08-06 Sunovion Pharmaceuticals Inc. Nonracemic mixtures and uses thereof
CA3142355A1 (en) 2019-06-04 2020-12-10 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56122311A (en) * 1980-02-29 1981-09-25 Eisai Co Ltd Lasting theophylline pharmaceutical composition
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
US4863744A (en) * 1984-09-17 1989-09-05 Alza Corporation Intestine drug delivery
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione

Also Published As

Publication number Publication date
TW222592B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-04-21
US5164193A (en) 1992-11-17
DE69128569T2 (de) 1998-04-16
EP0468436B1 (en) 1998-01-07
CA2046845A1 (en) 1992-01-26
JPH0482825A (ja) 1992-03-16
EP0468436A1 (en) 1992-01-29
KR0169319B1 (ko) 1999-01-15
KR930001899A (ko) 1993-02-22
DE69128569D1 (de) 1998-02-12
ES2111547T3 (es) 1998-03-16
CA2046845C (en) 2001-03-27

Similar Documents

Publication Publication Date Title
JP2572673B2 (ja) 徐放性錠剤
KR100305234B1 (ko) 장내목표부위에서의약적유효성분을방출하도록조정된약학적제제
JP2916978B2 (ja) 放出開始制御型製剤
KR100203339B1 (ko) 의약용 방출조절 매트릭스
US6372254B1 (en) Press coated, pulsatile drug delivery system suitable for oral administration
JP2519296B2 (ja) イブプロフェン除放性錠剤及びその製造方法
JP3611456B2 (ja) テオフィリン徐放性錠剤
US20110071137A1 (en) Process for preparing sustained release tablets
JP2002533380A (ja) 多孔性粒子を含む剤形
JPS5959633A (ja) 放出調整複合単位組成物の製法
EA018082B1 (ru) Препаративная форма для лечения гиперактивности при дефиците внимания, фармацевтическая композиция на ее основе и способ лечения гиперактивности при дефиците внимания
EP2375903A1 (en) A method of treating insomnia
JPS6056122B2 (ja) 徐放性製剤
BR112020021812A2 (pt) forma de dosagem, método para tratar uma doença, distúrbio, síndrome e/ou afecção em um paciente com necessidade do mesmo, e método para produzir uma forma de dosagem
JPH04257519A (ja) 徐放性経口投与型プラノプロフェン製剤
JPH0624991A (ja) ウルソデスオキシコール酸持続性製剤
JP2008521756A (ja) ピリドキサール−５’−ホスフェートの新規配合物及び調製方法
EP1556014A1 (en) Sustained release compositions containing alfuzosin
US7198803B2 (en) Sustained release oral preparations
KR20090086128A (ko) 메만틴 약학 조성물
JPH057367B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO2022200971A1 (en) A method for the production of gastroretentive compact matrices for the controlled release of active substances and compact matrices thus obtained
JPH04273816A (ja) パルス放出型有核錠
JP2006514672A (ja) 疎水性物質を徐放剤として含有する制御性放出製剤
JP3088051B2 (ja) バルプロ酸ナトリウムの徐放性錠剤

Legal Events

Date Code Title Description
S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071024

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081024

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081024

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091024

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101024

Year of fee payment: 14

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101024

Year of fee payment: 14